Oversight and Investigations

Chairman:  Tim Murphy (PA-18)
Jurisdiction: 
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.

Members

Republicans

Chairman: Tim Murphy (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Steve Scalise (LA)
Gregg Harper (MS)
Pete Olson (TX)
Cory Gardner (CO)
Morgan Griffith (VA)
Bill Johnson (OH)
Billy Long (MO)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Diana DeGette (CO)
Bruce Braley (IA)
Ben Ray Lujan (NM)
Jan Schakowsky (IL)
G.K. Butterfield (NC)
Kathy Castor (FL)
Peter Welch (VT)
Paul Tonko (NY)
John Yarmuth (KY)
Gene Green (TX)
John D. Dingell (MI) (non-voting)
Henry A. Waxman (CA)

May 16, 2013 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee leaders today continued their examination into reports that Health and Human Services Secretary Kathleen Sebelius may have solicited funding or assistance from the health care industry to help implement the health care law.

>>
May 13, 2013 | Press Release

The Subcommittee on Oversight and Investigations, chaired by Rep. Tim Murphy (R-PA), has scheduled a hearing for Monday, May 20, 2013, at 4 p.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Health Insurance Premiums Under the Patient Protection and Affordable Care Act.” Witnesses to be announced.

>>
May 13, 2013 | Letter

Exceprt: Since the week of February 18, 2013, through the last available listing in April 2013, the FDA's Public Calendar has listed Dr. Brenner-Gati as the Acting Deputy Commissioner for Medical Products and Tobacco with no significant meetings.

>>
May 13, 2013 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee leaders today expressed concern with recent press reports that Health and Human Services Secretary Kathleen Sebelius has solicited funding from private companies to help implement the health care law.

>>
May 13, 2013 | Letter

To read the letter to HHS, click here.

To read the letter to the following companies, click here.

>>

Pages